The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Adrenal Endocrinology
Volume 15 - 2024 |
doi: 10.3389/fendo.2024.1435102
This article is part of the Research Topic Progress and Pitfalls in Molecular and Biochemistry Diagnostics of Adrenal Tumors View all articles
Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma (2) Authors' names
Provisionally accepted- 1 Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
- 2 Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
- 3 Department of Urology, Sun Yat-sen Memorial Hospital, Guangzhou, China
Background: It is challenging for a clinician to distinguish adrenocortical carcinoma (ACC) from benign adrenocortical adenomas (ACA) in the early stage. This study explored the value of serum steroid profiling as a complementary biomarker for malignancy diagnosis ACC other than diameter, and explored the influence of sex and functional status on it.In this retrospective study, a matched cohort of patients diagnosed with either ACC or ACA based on histopathology was meticulously paired in a 1:1 ratio according to sex, age and functional status. Eight serum steroids including 11-deoxycortisol, 11deoxycorticosterone, progesterone, androstenedione, dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulfate (DHEAS), 17-hydroxyprogesterone and estradiol were quantified by liquid chromatography tandem mass spectrometry. We conducted a comparative analysis of clinical characteristics and serum steroid profiling between patients with ACC and ACA, with further subgroup analysis.The study examined 31 patients with ACC and 31 matched patients with ACA.Patients with ACC exhibited significantly larger tumor diameters, lower body mass index (BMI), and higher level of 11-deoxycortisol, progesterone, and androstenedione compared to those with ACA. 11-deoxycortisol was the only valuable index for discriminating ACC with ACA regardless of its functional status and sex. Progesterone, DHEA and DHEAS were higher in functional ACC group, not in non-functional ACC.Female ACC patients especially in post-menopausal female exhibited higher levels of androstenedione, not in male. The area under curve of tumor diameter, 11-deoxycortisol and BMI was 0.947 (95% CI 0.889-1.000), with the sensitivity of 96.8% and specificity of 90.3%.Serum steroid profiling serves as a helpful discriminative marker for ACC and ACA, with 11-deoxycortisol being the most valuable one. For other steroid hormones, consideration of sex differences and functional status is crucial.
Keywords: Adrenocortical Carcinoma, Adrenocortical Adenoma, serum steroid profiling, LC-MS/MS, diagnosis
Received: 19 May 2024; Accepted: 26 Aug 2024.
Copyright: © 2024 Weng, Tang, Zhang, Lin, Guo, Liang, Wang, Zhou, Yan, Lin and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Tianxin Lin, Department of Urology, Sun Yat-sen Memorial Hospital, Guangzhou, China
Shaoling Zhang, Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.